Dominika Kędzia

Mrs. Dominika Kędzia

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
DKDominika Kędzia
Dominika Kędzia
GGGrzegorz Galita
Grzegorz Galita
IMIreneusz Majsterek
Ireneusz Majsterek
WRWioletta Rozpędek-Kamińska
Wioletta Rozpędek-Kamińska
Parkinson’s disease (PD) is a progressive neurodegenerative disorder marked by the degeneration of dopaminergic neurons in the substantia nigra, resulting in cardinal motor symptoms such as tremor, rigidity, and bradykinesia. Neuroinflammation is increasingly recognized as a central driver of PD onset and progression in which oligodendrocytes, astrocytes, and microglia engage in complex bidirectional crosstalk that shapes the inflammatory milieu of the central nervous system. Pathological activation of glial cells triggers the release of pro-inflammatory cytokines, chemokines, and reactive oxygen species, thereby exacerbating neuronal injury and contributing to sustained disease progression. Modulating maladaptive glial activation states and their intercellular communication represents a promising therapeutic avenue aimed at mitigating neuroinflammation and slowing PD pathology. This review synthesizes current knowledge on neuroinflammation in PD, focusing on the distinct roles of microglia, astrocytes, and oligodendrocytes, their interaction networks, and emerging therapeutic strategies.

Verified
Journal Article
Open access
PDF file
KSKatarzyna Stańczyk
Katarzyna Stańczyk
OŁOlga Łopacińska
Olga Łopacińska
DKDominika Kędzia
Dominika Kędzia
Oliwia Gawlik-KotelnickaOliwia Gawlik-Kotelnicka
Oliwia Gawlik-Kotelnicka
Background/Objectives: Polycystic ovary syndrome (PCOS) is the most commonly diagnosed endocrine disorder in women of reproductive age, with a prevalence estimated at 4–20%. Among the conditions often co-occurring with PCOS are depressive and anxiety disorders. The aim of this study was to determine the prevalence of depressive and anxiety symptoms in women with PCOS. Methods: A literature search was conducted using PubMed/MEDLINE, Google Scholar, and Directory of Open Access Journals databases for studies published before May 2025. The analysis was conducted on a group of 5857 women (study group: 3610; control group: 2247) obtained from 35 studies, which met the inclusion criteria. Results: The prevalence of depressive symptoms in PCOS patients and the controls, according to the BDI, HADS-D, Mini-NPI and PHQ assessment tool, was 42.11% (95% CI: 32.6–52.2) vs. 13.62% (95% CI: 8.4–21.5; p < 0.001); 28.90% (95% CI: 20.7–38.8) vs. 15.80% (95% CI: 11.3–21.7; p = 0.010); 59.10% (95% CI: 30.9–82.4) vs. 65.90% (95% CI: 24.2–92.1; p = 0.792); and 26.50% (95% CI: 8.0–59.9) vs. 9.10% (95% CI: 1.8–35.1; p = 0.255). The prevalence of anxiety symptoms in the PCOS group and the control group, according to the HADS-A assessment tool, was 48.25% (95% CI: 36.1–60.6) vs. 31.40% (95% CI: 18.8–47.4; p = 0.098), respectively. Conclusions: The study confirms the higher prevalence of depressive symptoms in women with PCOS compared to the general population. These findings indicate the necessity of conducting psychiatric examinations and providing support for women with PCOS.

12 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EBEwelina Anna Barszcz
Ewelina Anna Barszcz
MPMaksymilian Kamil Plewka
Maksymilian Kamil Plewka
AMAleksandra Margulska
Aleksandra Margulska
DKDominika Kędzia
Dominika Kędzia
KSKlaudia Sójta
Klaudia Sójta
Oliwia Gawlik-KotelnickaOliwia Gawlik-Kotelnicka
Oliwia Gawlik-Kotelnicka
Background: Postnatal bonding reflects the early emotional relationship between a mother and her infant and is shaped by psychological and perinatal factors. This study examined associations between postnatal bonding and maternal depressive symptoms, resilience, labor anxiety, and sociodemographic and health-related variables, as well as anxiety related to the COVID-19 pandemic, the war in Ukraine, and global events. Methods: This prospective cohort study included and followed 150 pregnant women in Poland from pregnancy to 12 months postpartum. Assessments were conducted during pregnancy and at 4–6 weeks, 6 months, and 12 months after delivery. Postnatal bonding was assessed using the PBQ, depressive symptoms with the EPDS, labor anxiety with the LAQ, resilience with the KOP-26, and anxiety related to external stressors with study-specific questionnaires. Non-parametric analyses were performed with a significance level of p < 0.05. Results: Postnatal bonding difficulties were most prevalent at 4–6 weeks postpartum (26.1%) and decreased over time. Maternal depressive symptoms showed the strongest and most consistent associations with bonding difficulties, whereas higher resilience, particularly in family relations and social competence, was associated with better bonding outcomes. Labor anxiety was weakly associated with bonding only in the early postpartum period, while no associations were found with sociodemographic characteristics or anxiety related to external societal stressors. Conclusions: Maternal depressive symptoms and resilience emerged as the key factors associated with postnatal bonding quality, highlighting their importance as targets for early identification and intervention.